BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 6124876)

  • 1. In vitro and in vivo binding characteristics of a new long-acting histamine H1 antagonist, astemizole.
    Laduron PM; Janssen PF; Gommeren W; Leysen JE
    Mol Pharmacol; 1982 Mar; 21(2):294-300. PubMed ID: 6124876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Non-sedative antihistaminics and binding to central and peripheral H1 histamine receptors].
    Leysen JE; Gommeren W; Janssen PF; Sanz G; Gillardin JM; Schotte A; Janssen PA
    Allerg Immunol (Paris); 1991 Feb; 23(2):51-7. PubMed ID: 1677249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
    Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM
    Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent.
    Benavides J; Schoemaker H; Dana C; Claustre Y; Delahaye M; Prouteau M; Manoury P; Allen J; Scatton B; Langer SZ
    Arzneimittelforschung; 1995 May; 45(5):551-8. PubMed ID: 7612054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical method for simultaneously measuring ex vivo drug receptor occupancy and dissociation rate: application to (R)-dimethindene occupancy of central histamine H1 receptors.
    Malany S; Hernandez LM; Smith WF; Crowe PD; Hoare SR
    J Recept Signal Transduct Res; 2009; 29(2):84-93. PubMed ID: 19308787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of an effect of terfenadine on guinea pig brain histamine H1-receptors in vivo determined by receptor binding techniques.
    Wiech NL; Martin JS
    Arzneimittelforschung; 1982; 32(9a):1167-70. PubMed ID: 6817763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacology of astemizole (Hismanal) a non-sedating H1 antihistaminic].
    Niemegeers CJ
    Z Hautkr; 1985; 60 Suppl 1():14-22. PubMed ID: 2581383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo studies of the non-sedating antihistamine epinastine.
    Fügner A; Bechtel WD; Kuhn FJ; Mierau J
    Arzneimittelforschung; 1988 Oct; 38(10):1446-53. PubMed ID: 2461715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiallergic effects of major metabolites of astemizole in rats and guinea pigs.
    Kamei C; Mio M; Izushi K; Kitazumi K; Tsujimoto S; Fujisawa K; Adachi Y; Tasaka K
    Arzneimittelforschung; 1991 Sep; 41(9):932-6. PubMed ID: 1724600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal pharmacology of the selective histamine H1-receptor antagonist tazifylline.
    Poizot A; Dumez D; Ferrandon P; Lefournier C; Michel A; Armstrong JM
    Arzneimittelforschung; 1986 Apr; 36(4):695-702. PubMed ID: 2424463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo pharmacology of astemizole, a new type of H1-antihistaminic compound.
    Van Wauwe J; Awouters F; Neimegeers CJ; Janssens F; Van Nueten JM; Janssen PA
    Arch Int Pharmacodyn Ther; 1981 May; 251(1):39-51. PubMed ID: 6114717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-ethylmaleimide-induced changes in agonist affinity for histamine H1-receptors in the guinea pig brain.
    Yeramian E; Garbarg M; Schwartz JC
    Mol Pharmacol; 1985 Aug; 28(2):155-62. PubMed ID: 4022000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a difference in the affinity of histamine H1 receptor antagonists for CNS and peripheral receptors? An in vitro study.
    Ter Laak AM; Donné-Op den Kelder GM; Bast A; Timmerman H
    Eur J Pharmacol; 1993 Mar; 232(2-3):199-205. PubMed ID: 8096817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of histamine H1 binding sites on human T lymphocytes by means of 125I-iodobolpyramine. Preferential expression of H1 receptors on CD8 T lymphocytes.
    Villemain FM; Bach JF; Chatenoud LM
    J Immunol; 1990 Feb; 144(4):1449-54. PubMed ID: 1968079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of the antihistamine effect of TAK-427, a novel imidazopyridazine derivative.
    Fukuda S; Midoro K; Yamasaki M; Gyoten M; Kawano Y; Fukui H; Ashida Y; Nagaya H
    Inflamm Res; 2003 May; 52(5):206-14. PubMed ID: 12813625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temperature dependence of the binding of [3H]mepyramine and related compounds to the histamine H1 receptor.
    Wallace RM; Young JM
    Mol Pharmacol; 1983 Jan; 23(1):60-6. PubMed ID: 6135145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the pharmacology of the novel histamine H3 receptor agonist Sch 50971.
    Hey JA; Aslanian R; Bolser DC; Chapman RW; Egan RW; Rizzo CA; Shih NY; Fernandez X; McLeod RL; West R; Kreutner W
    Arzneimittelforschung; 1998 Sep; 48(9):881-8. PubMed ID: 9793613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [3H]Mianserin: differential labeling of serotonin and histamine receptors in rat brain.
    Peroutka SJ; Snyder SH
    J Pharmacol Exp Ther; 1981 Jan; 216(1):142-8. PubMed ID: 6109019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the [3H]mepyramine binding site represent the histamine H1 receptor? Re-examination of the histamine H1 receptor with quinine.
    Liu Q; Horio Y; Fujimoto K; Fukui H
    J Pharmacol Exp Ther; 1994 Feb; 268(2):959-64. PubMed ID: 8114011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular properties of central and peripheral histamine H1 and H2 receptors.
    Carman-Krzan M; Lipnik-Stangelj M
    Pflugers Arch; 2000; 439(3 Suppl):R131-2. PubMed ID: 10653166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.